The Rockefeller University - Bridges to Better Medicine

[ Log In | Register ]

Events

Technology Transfer

Membership

Contact

Home

   Marc Tessier-Lavigne
   President
   The Rockefeller University

MODERATOR

Barry Coller, M.D.
Vice President for Medical
Affairs and
Physician-in-Chief
The Rockefeller University

Director
Center for Clinical and
Translational Science

CO-CHAIRS

   Anthony B. Evnin, Ph.D.
   General Partner
   Venrock

   Robin Chemers Neustein
   Senior Director
   Goldman, Sachs & Co.

STEERING COMMITTEE

Ron Cohen, M.D.
Acorda Therapeutics

Kathleen Denis, Ph.D.
The Rockefeller University

David Elliman
Elmrock Capital

Emilio Emini, Ph.D.
Pfizer

Teena Lerner, Ph.D.
Rx Capital Management

Paul Maddon, M.D., Ph.D.
Progenics Pharmaceuticals

Brad Margus
Envoy Therapeutics

Sharon Mates, Ph.D.
Intra-Cellular Therapies

Robin Chemers Neustein
Goldman, Sachs & Co.

Russell Pennoyer
Benedetto, Gartland & Co.

Geoff Smith
Ascent Biomedical Ventures

   George Yancopoulos,
   M.D., Ph.D.
   Regeneron Pharmaceuticals

CONTACT

bridges@rockefeller.edu

Bridges to Better Medicine brings together world class scientists and business leaders in the life sciences - venture capitalists, biotechnology and pharmaceutical executives, healthcare investors and analysts. The Rockefeller University believes that fostering a robust intellectual exchange between academia and industry is critical to advancing biomedical breakthroughs.

Bridges offers you opportunities to:

hear about the latest scientific and medical innovations from inside the lab and from industry;
interact with top scientists and industry leaders in a private setting;
develop valuable relationships and exchange ideas with peers.

Through this program, The Rockefeller University hopes to develop friendships and inspire philanthropy among individuals in life science-related businesses.

» Register

to become a member

UPCOMING EVENTS

Check back soon for information on upcoming events....

If you have questions, or would like to make suggestions for future programs, please call (212) 327-8910 or email bridges@rockefeller.edu.

BREAKING NEWS

November 17, 2011
Statin-intolerant patients need a different type of clinical trial
Although only 5% of people in clinical trials report side effects from statin drugs, in practice the problem is far greater. Clinical trials need to better address the needs of statin-intolerant patients, Rockefeller researchers say.

November 3, 2011
University joins 10 leading medical and research institutions to form New York Genome Center
The new facility, one of the largest in North America and to begin operations in mid-2012, is designed to accelerate progress toward a new era of genome-based research and medicine.

October 3, 2011
Rockefeller University scientist Ralph Steinman, honored today with Nobel Prize for discovery of dendritic cells, dies at 68

September 20, 2011
Rockefeller lab to receive "transformative" $2.1 million grant to study 'decorator' trypanosome proteins
The Laboratory of Lymphocyte Biology, under the direction of F. Nina Papavasiliou, has received the grant from the National Institutes of Health Common Fund.

July 22, 2011
Rockefeller University receives $36.1 million to help translate science into cures
Rockefeller University’s Center for Clinical and Translational Science (CCTS), a center aimed at accelerating the pace of translating science into real-life solutions for patients, has received $36.1 million from the National Institutes of Health to expand its work over the next five years.